Replication study of association between ADCYAP1 gene polymorphisms and schizophrenia

Psychiatric Genetics

Volumn 20, Issue 3, 2010, Pages 123-125

  Koga, Minori ^a,b   Ishiguro, Hiroki ^a,b   Horiuchi, Yasue ^a,b   Inada, Toshiya ^c   Ujike, Hiroshi ^f   Itokawa, Masanari ^d   Otowa, Takeshi ^e   Watanabe, Yuichiro ^g   Someya, Toshiyuki ^g   Arinami, Tadao ^a,b  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c SEIWA HOSPITAL   (Japan)

^d TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

^f OKAYAMA UNIVERSITY   (Japan)

^g NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Adenylate cyclase activating polypeptide 1; Genetic association; Pituitary adenylate cyclase activating polypeptide; Replication study; Schizophrenia

Indexed keywords

ASPARTIC ACID; GLYCINE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; NEUROPEPTIDE;

ADCYAP1 GENE; ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; NEUROTRANSMISSION; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JAPAN; MALE; MIDDLE AGED; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA;

EID: 77953811316     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/YPG.0b013e32833a1f52     Document Type: Article

References (11)

1. Arimura A (1998). Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems. Jpn J Physiol 48:301-331.
2. Cannon TD, Kaprio J, Lonnqvist J, Huttunen M, Koskenvuo M (1998). The genetic epidemiology of schizophrenia in a Finnish twin cohort. A population-based modeling study. Arch Gen Psychiatry 55:67-74.
3. DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials 7:177-188.
4. Hashimoto H, Shintani N, Tanaka K, Mori W, Hirose M, Matsuda T, et al. (2001). Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP). Proc Natl Acad Sci U S A 98:13355-13360.
5. Hashimoto H, Shintani N, Baba A (2002). Higher brain functions of PACAP and a homologous Drosophila memory gene amnesiac: insights from knockouts and mutants. Biochem Biophys Res Commun 297:427-431.
6. Hashimoto R, Hashimoto H, Shintani N, Chiba S, Hattori S, Okada T, et al. (2007). Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia. Mol Psychiatry 12:1026-1032.
7. Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748.
8. Nurnberger JI Jr, Foroud T (2000). Genetics of bipolar affective disorder. Curr Psychiatry Rep 2:147-157.
9. Tanaka K, Shintani N, Hashimoto H, Kawagishi N, Ago Y, Matsuda T, et al. (2006). Psychostimulant-induced attenuation of hyperactivity and prepulse inhibition deficits in Adcyap1-deficient mice. J Neurosci 26:5091-5097.
10. Vaudry D, Gonzalez BJ, Basille M, Yon L, Fournier A, Vaudry H (2000). Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol Rev 52:269-324.
11. Yamaguchi-Kabata Y, Nakazono K, Takahashi A, Saito S, Hosono N, Kubo M et al. (2008). Japanese population structure, based on SNP genotypes from 7003 individuals compared to other ethnic groups: effects on population-based association studies. Am J Hum Genet 83:445-456.